Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals

Frontiers in Aging Neuroscience
Soghra BagheriAli A Saboury

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by amyloid plaques in patients' brain tissue. The plaques are mainly made of β-amyloid peptides and trace elements including Zn2+, Cu2+, and Fe2+. Some studies have shown that AD can be considered a type of metal dyshomeostasis. Among metal ions involved in plaques, numerous studies have focused on copper ions, which seem to be one of the main cationic elements in plaque formation. The involvement of copper in AD is controversial, as some studies show a copper deficiency in AD, and consequently a need to enhance copper levels, while other data point to copper overload and therefore a need to reduce copper levels. In this paper, the role of copper ions in AD and some contradictory reports are reviewed and discussed.

References

May 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M D WeingartenM W Kirschner
Jan 1, 1990·Acta Neuropathologica·I Grundke-IqbalJ G Joshi
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Apr 21, 1995·The Journal of Biological Chemistry·M B PodlisnyD J Selkoe
Nov 1, 1993·Journal of Neurochemistry·C Vigo-PelfreyD B Schenk
Jan 1, 1997·Life Sciences·A de Mendonça, J A Ribeiro
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A SmithG Perry
Jul 17, 1998·Journal of the Neurological Sciences·M A LovellW R Markesbery
May 27, 1999·Annals of Medicine·T Porkka-Heiskanen
Jul 20, 1999·European Journal of Clinical Investigation·C GonzálezJ M González-Buitrago
Aug 7, 1999·The Journal of Biological Chemistry·R A ChernyA I Bush
Aug 17, 1999·Neurobiology of Disease·D J WaggonerJ D Gitlin
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·O YermolaievaT Hoshi
Sep 1, 2000·Brain Research. Brain Research Reviews·L BuéeP R Hof
Feb 27, 2001·Medicinal Research Reviews·G CristalliE Camaioni
Mar 29, 2001·Physiological Reviews·D J Selkoe
Jul 27, 2001·Biochemical and Biophysical Research Communications·K SuzukiH Takeuchi
Mar 14, 2002·European Journal of Pharmacology·Grace S PereiraCarla D Bonan
Jul 19, 2002·Nature·Hilal A LashuelPeter T Lansbury
Sep 7, 2002·The Journal of Biological Chemistry·Christa J MaynardQiao-Xin Li
Sep 19, 2002·Journal of Neuroscience Research·Lauren T Knapp, Eric Klann
Feb 11, 2003·Progress in Neurobiology·J A RibeiroA de Mendonça
Aug 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·D Larry Sparks, Bernard G Schreurs
Sep 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ashley I BushRudolph E Tanzi
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Amie L PhinneyDavid Westaway
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thomas A BayerGerd Multhaup
Jan 8, 2004·Journal of the American Chemical Society·Tadashi TerasakaIsao Nakanishi

❮ Previous
Next ❯

Citations

May 12, 2018·Dalton Transactions : an International Journal of Inorganic Chemistry·Duraippandi PalanimuthuDanuta S Kalinowski
Apr 11, 2019·Physical Chemistry Chemical Physics : PCCP·Giovanni La Penna, Mai Suan Li
Oct 24, 2019·Current Alzheimer Research·Alessandra MiceraRosanna Squitti
Dec 10, 2019·Current Pharmaceutical Design·Giuseppe CarusoSara Merlo
Feb 12, 2020·International Journal of Molecular Sciences·Silvia BaldariGabriele Toietta
Jun 4, 2020·International Journal of Molecular Sciences·Olga KrasnovskayaAlexander Majouga
Aug 18, 2020·Journal of Alzheimer's Disease : JAD·Bianca Maria CiminelliPatrizia Malaspina
Jun 20, 2019·Nutrients·Ludmila V PuchkovaRoman S Polishchuk
Dec 15, 2019·Cells·Muhammad Umair, Majid Alfadhel
Mar 12, 2020·Biomolecules·Alexander PilozziXudong Huang
Jun 23, 2020·Journal of Alzheimer's Disease : JAD·Johant Lakey-BeitiaK S Rao
Oct 20, 2020·Frontiers in Molecular Neuroscience·Klara ZubčićMaja Jazvinšćak Jembrek
Oct 22, 2020·International Journal of Molecular Sciences·Hafza Wajeeha EjazMinglin Lang
Jan 24, 2020·Current Neuropharmacology·Hareram BirlaSandeep Kumar Singh
Oct 27, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Frédéric MoynierClaire Paquet
Dec 10, 2020·International Journal of Molecular Sciences·Grażyna GromadzkaAgata Adamczyk
Dec 17, 2020·Journal of Alzheimer's Disease : JAD·Amalia MerelliJerónimo Auzmendi
Jan 13, 2021·Toxics·Roshni Patel, Michael Aschner
Feb 20, 2021·Redox Biology·Viktoria K WandtTanja Schwerdtle
Mar 11, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Christina Liu, Xuan Luo
Oct 4, 2020·Neurochemistry International·Maryam VasefiAnthony Osu
May 14, 2021·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Monika Cendrowska-PinkoszKatarzyna Ognik
Jun 3, 2021·International Journal of Molecular Sciences·Antonio MagrìEnrico Rizzarelli
Jun 25, 2021·Chemical Science·Arnab Kumar NathSomdatta Ghosh Dey
Jun 4, 2020·Drug Discovery Today·Maria Antònia Busquets, Joan Estelrich
Aug 8, 2021·International Journal of Molecular Sciences·Beata TarnackaMaria Maślińska

❮ Previous
Next ❯

Methods Mentioned

BETA
deamination
transgenic

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.